Advertisement NAFLD/NASH Medications Tweet × Share Twitter Facebook Pinterest Tumblr Email Copy Link Share Print The NAFLD/NASH medications' page includes specific information about each of the experimental drugs in later phases of development for treatment of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Quick Links NAFLD/NASH Medications Quick Filter Select list: Select Drug TAK-652, TBR-652 GFT505 OCA GS-4997 IDN-6556, PF-03491390 GS-9674 GS-0976 BMS-986036 LJN452 *generic or biosimilar available E experimental NAFLD/NASH Medications Learn more >> More >> DRUG ABBRV. GENERIC NAME E cenicriviroc CVC cenicriviroc E elafibranor N/A elafibranor E Ocaliva OCA obeticholic acid E selonsertib N/A selonsertib E emricasan N/A emricasan E cilofexor N/A N/A E firsocostat N/A N/A E pegbelfermin N/A pegbelfermin E tropifexor N/A tropifexor Multi-Class Combination Drugs More >> DRUG cenicriviroc E ABBRV. CVC GENERIC NAME cenicriviroc DRUG elafibranor E ABBRV. N/A GENERIC NAME elafibranor DRUG Ocaliva E ABBRV. OCA GENERIC NAME obeticholic acid DRUG selonsertib E ABBRV. N/A GENERIC NAME selonsertib DRUG emricasan E ABBRV. N/A GENERIC NAME emricasan DRUG cilofexor E ABBRV. N/A GENERIC NAME N/A DRUG firsocostat E ABBRV. N/A GENERIC NAME N/A DRUG pegbelfermin E ABBRV. N/A GENERIC NAME pegbelfermin DRUG tropifexor E ABBRV. N/A GENERIC NAME tropifexor Read More About: #Bristol Myers Squibb #Cenicriviroc #fatty liver disease #Gilead Sciences #NASH #Novartis #NAFLD #Selonsertib #elafibranor #Emricasan #Pegbelfermin #Ocaliva #Intercept Pharmaceuticals #Genfit #firsocostat #cilofexor #tropifexor Advertisement RELATED articles NAFLD Linked to Higher Risk for Cancers Outside the Liver Fatty Liver Disease Is Global Long-Term Exposure to Secondhand Smoke Is Associated With Fatty Liver Disease Fatty Liver Disease Is Highly Prevalent Worldwide
